Abilify and Enoxaparin sodium drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Abilify (aripiprazole) and Enoxaparin sodium (enoxaparin sodium). Common drug interactions include chest pain among females and extrapyramidal disorder among males.
The phase IV clinical study analyzes what interactions people have when they take Abilify and Enoxaparin sodium. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.
What is Enoxaparin sodium?
Enoxaparin sodium has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 24,181 Enoxaparin sodium users. Check the latest studies of Enoxaparin sodium.
48 people who take Abilify and Enoxaparin sodium together, and have interactions are studied.

What are the common drug interactions of Abilify and Enoxaparin Sodium, by gender? *:
female:
- Chest pain
- Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Spinal stenosis (narrowing of spinal column)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
- Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
- C-reactive protein increased
- Drug effect decreased
- Fear
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
male:
- Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
- Agitation (state of anxiety or nervous excitement)
- Arthropathy
- Bradycardia (abnormally slow heart action)
- Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
- Conduction disorder (serious disorder of the heart not responses proper to impulses)
- Electrocardiogram qt corrected interval prolonged
- Febrile neutropenia (fever with reduced white blood cells)
- Heart rate increased
- Hypertension (high blood pressure)
What are the common drug interactions of Abilify and Enoxaparin Sodium, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Psychiatric decompensation (worsening of symptoms to the state of a serious mental disorder)
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Death
- Bone marrow toxicity (decrease in cells responsible for providing immunity, carrying oxygen, and those responsible for normal blood clotting)
- C-reactive protein increased
- Mood altered (changes in mood)
- Pneumonia
- Pyrexia (fever)
- Suicidal behaviour
30-39:
- Anxiety
- Arthralgia (joint pain)
- Emotional distress
- Fracture
- Fractured sacrum
- Gait disturbance
- Hip fracture
- Joint dislocation (a joint position is changed from normal position)
- Joint injury
- Nephropathy (damage to or disease of a kidney)
40-49:
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Heart rate irregular
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Spinal stenosis (narrowing of spinal column)
- Swelling
- Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
- Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
- Conduction disorder (serious disorder of the heart not responses proper to impulses)
- Dizziness
- Electrocardiogram qt corrected interval prolonged
50-59:
- Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
- Pulmonary congestion (congestion in the lungs)
- Respiratory distress (difficulty in breathing)
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Neuropathy peripheral (surface nerve damage)
- Altered state of consciousness (altered state of mind)
- Anxiety disorder
- Arthralgia (joint pain)
- Arthropathy
- Asthenia (weakness)
60+:
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Pneumonia
- Azotaemia (excess of urea or other nitrogenous compounds in the blood)
- Back pain
- Bone disorder
- Cellulitis (infection under the skin)
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Compression fracture (fracture due to pressure caused by injury)
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Cough
What are the existing conditions these people have? *
- Pain: 7 people, 14.58%
- Bipolar Disorder (mood disorder): 6 people, 12.50%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 10.42%
- Embolism Arterial (blood clot that has travelled through your arteries and become stuck): 5 people, 10.42%
- Insomnia (sleeplessness): 3 people, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and Enoxaparin sodium?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Abilify (101,454 reports)
- Enoxaparin sodium (24,181 reports)
Browse all drug interactions of Abilify and Enoxaparin sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Enoxaparin sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Abilify and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Enoxaparin sodium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole and enoxaparin sodium (the active ingredients of Abilify and Enoxaparin sodium, respectively), and Abilify and Enoxaparin sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Cytotec and Centrum - 9 seconds ago
- Drug interactions of Aranesp and Dulcolax - 11 seconds ago
- Drug interactions of Lamotrigine and Clonidine Hydrochloride - 25 seconds ago
- Vitamin B3 vs. B Complex Vitamin, side effect and effectiveness comparison - 31 seconds ago
- Could Olopatadine Hydrochloride cause Fluid Retention? - 40 seconds ago
- Drug interactions of Amitriptyline Hydrochloride and Turmeric - 47 seconds ago
- Could Caffeine cause Head Injury? - a minute ago
- Drug interactions of Multivitamin and Orenitram - a minute ago
- Metastatic Renal Cell Carcinoma and Renal Failure Chronic Aggravated - a minute ago
- Hypericum Perforatum vs. Topamax, side effect and effectiveness comparison - a minute ago